Terms: = Lymphoma AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM
293 results:
1. Metabolic Profiling as an Approach to Differentiate T-Cell Acute Lymphoblastic Leukemia Cell Lines Belonging to the Same Genetic Subgroup.
Alabed HBR; Pellegrino RM; Buratta S; Lema Fernandez AG; La Starza R; Urbanelli L; Mecucci C; Emiliani C; Gorello P
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612731
[TBL] [Abstract] [Full Text] [Related]
2. Interventional treatment of refractory non-traumatic chylous effusions in patients with lymphoproliferative disorders.
Wagenpfeil J; Hoß K; Henkel A; Kütting D; Luetkens JA; Feldmann G; Brossart P; Attenberger UI; Pieper CC
Clin Exp Med; 2024 Mar; 24(1):63. PubMed ID: 38554229
[TBL] [Abstract] [Full Text] [Related]
3. Changes in mortality associated with different hematologic malignancies during the pandemic in the United States.
Fedeli U; Barbiellini Amidei C; Han X; Jemal A
Int J Cancer; 2024 May; 154(10):1703-1708. PubMed ID: 38335457
[TBL] [Abstract] [Full Text] [Related]
4. The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.
Pedersen MA; Gormsen LC; Jakobsen LH; Eyre TA; Severinsen MT; Baech J; Dann EJ; Knapp A; Sahin D; Vestergaard P; El-Galaly TC; Jensen P
Br J Haematol; 2024 Apr; 204(4):1271-1278. PubMed ID: 37957542
[TBL] [Abstract] [Full Text] [Related]
5. Unique synapomorphies and high diversity in South American Raji-related Epstein-Barr virus genomes.
Alves P; Emmel V; Stefanoff G; Krsticevic F; Ezpeleta J; Murillo J; Tapia E; Delatorre E; Abdelhay E; Hassan R
Mem Inst Oswaldo Cruz; 2023; 118():e230122. PubMed ID: 37937604
[TBL] [Abstract] [Full Text] [Related]
6. Associations between BMI in youth and site-specific cancer in men-A cohort study with register linkage.
Onerup A; Mehlig K; Af Geijerstam A; Ekblom-Bak E; Kuhn HG; Lissner L; Rosengren A; Börjesson M; Åberg M
Obesity (Silver Spring); 2024 Feb; 32(2):376-389. PubMed ID: 37927128
[TBL] [Abstract] [Full Text] [Related]
7. Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell lymphoma.
Lin LH; Ghasemi M; Burke SM; Mavis CK; Nichols JR; Torka P; Mager DE; Hernandez-Ilizaliturri FJ; Goey AKL
Target Oncol; 2023 Sep; 18(5):685-695. PubMed ID: 37632592
[TBL] [Abstract] [Full Text] [Related]
8. ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular lymphoma.
Zinzani PL; Mayer J; Flowers CR; Bijou F; De Oliveira AC; Song Y; Zhang Q; Merli M; Bouabdallah K; Ganly P; Zhang H; Johnson R; Martín García-Sancho A; Provencio Pulla M; Trněný M; Yuen S; Tilly H; Kingsley E; Tumyan G; Assouline SE; Auer R; Ivanova E; Kim P; Huang S; Delarue R; Trotman J
J Clin Oncol; 2023 Nov; 41(33):5107-5117. PubMed ID: 37506346
[TBL] [Abstract] [Full Text] [Related]
9. Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysis.
Awad AK; Awan RU; Awad AK; Nabeel A; Dar S; Abegunde AT
Cancer Treat Res Commun; 2023; 36():100745. PubMed ID: 37499419
[TBL] [Abstract] [Full Text] [Related]
10. Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.
Kaulen LD; Denisova E; Hinz F; Hai L; Friedel D; Henegariu O; Hoffmann DC; Ito J; Kourtesakis A; Lehnert P; Doubrovinskaia S; Karschnia P; von Baumgarten L; Kessler T; Baehring JM; Brors B; Sahm F; Wick W
Acta Neuropathol; 2023 Sep; 146(3):499-514. PubMed ID: 37495858
[TBL] [Abstract] [Full Text] [Related]
11. Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non-Carfilzomib-Based Regimens in the United States by Race.
Li S; Suehs BT; Fu A; Sangaré L; Kim C; Gastanaga VM; Liu J; Yan H; Xu Y; Mikhael J
Clin Lymphoma Myeloma Leuk; 2023 Aug; 23(8):616-625. PubMed ID: 37258396
[TBL] [Abstract] [Full Text] [Related]
12. [The efficacy and safety of low-dose chemotherapy combined with tyrosine kinase inhibitors in the treatment of Philadelphia-chromosomal-positive acute lymphoblastic leukemia].
Wang H; Zhao T; Hu LJ; Li ZR; Jiang H; Qin YZ; Lai YY; Shi HX; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):550-556. PubMed ID: 36709131
[No Abstract] [Full Text] [Related]
13. Clinical course, long-term outcomes, and chemotherapy toxicity profile in B-cell Non-Hodgkin lymphoma in children: Single institution experience of Pakistan.
Rehman P; Wali RM
J Pak Med Assoc; 2022 Oct; 72(10):1988-1993. PubMed ID: 36660986
[TBL] [Abstract] [Full Text] [Related]
14. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL.
Li S; Qiu L; Xu J; Lin P; Ok CY; Tang G; McDonnell TJ; James You M; Khanlari M; Miranda RN; Medeiros LJ
Leukemia; 2023 Feb; 37(2):422-432. PubMed ID: 36513804
[TBL] [Abstract] [Full Text] [Related]
15. Expression analysis of circulating miR-22, miR-122, miR-217 and miR-367 as promising biomarkers of acute lymphoblastic leukemia.
Hosseinpour-Soleimani F; Khamisipour G; Derakhshan Z; Ahmadi B
Mol Biol Rep; 2023 Jan; 50(1):255-265. PubMed ID: 36327023
[TBL] [Abstract] [Full Text] [Related]
16. Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas.
Sengar M; Jain H; Shet T; Sridhar E; Gota V; Rangarajan V; Laskar SS; Alahari A; Thorat J; Agarwal A; Sharma N; Gupta H; Kannan S; Kumar S; Nayak L; Menon H; Gujral S; Bagal B
Br J Haematol; 2023 Feb; 200(4):429-439. PubMed ID: 36323643
[TBL] [Abstract] [Full Text] [Related]
17. [Mid-term efficacy of China Net Childhood lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
[No Abstract] [Full Text] [Related]
18. Survival Outcomes of Patients with Mycosis Fungoides Involving the External Ear and Ear Canal.
Wilkinson AJ; Nader ME; Roberts D; Duvic M; Gunther JR; Dabaja BS; Gidley PW
Laryngoscope; 2023 Jun; 133(6):1486-1491. PubMed ID: 36054317
[TBL] [Abstract] [Full Text] [Related]
19. The cost-effectiveness of brigatinib in adult patients with ALK inhibitor-naive ALK-positive non-small cell lung cancer from a US perspective.
Cranmer H; Kearns I; Young M; Humphries MJ; Trueman D
J Manag Care Spec Pharm; 2022 Sep; 28(9):970-979. PubMed ID: 36001099
[No Abstract] [Full Text] [Related]
20. Patterns and temporal trends in the incidence of childhood and adolescence cancer in Cyprus 1998-2017: A population-based study from the Cyprus Paediatric Oncology Registry.
Loizou L; Demetriou A; Erdmann F; Borkhardt A; Brozou T; Sharp L; McNally R
Cancer Epidemiol; 2022 Oct; 80():102239. PubMed ID: 35994888
[TBL] [Abstract] [Full Text] [Related]
[Next]
